Glory Bio
Glory Bio

language

Menu

Glory Bio

Zhejiang Honor Biotechnology Co., Ltd.

Phone: +86 0576 85589125

Email: zhaoqiang.peng@rongyaobiotech.com

Address: No. 30, Duchuan South Road, Linhai Industrial Park, Zhejiang Province Chemical API Base

Glory Bio
English
Select Language
Current language: Chinese
Chinese English
RONGYAO BIOTECH
Glory Bio

Dedicated to Pet Health

More →
scroll down

BRWNN

HONOR

Zhejiang Honor Biotechnology Co., Ltd. was founded in 1999.

Located in the Taizhou Bay Economic and Technological Development Zone, a national-level economic and technological development zone, it is an enterprise integrating research and development, production,

An innovative pharmaceutical enterprise integrating sales

...

Passed six consecutive times US FDA certification

Passed four consecutive times Domestic GMP certification

National High-Tech Enterprise

National-level Postdoctoral Research Station

Provincial High-tech Enterprise Research and Development Center

Provincial-level Enterprise Research Institute

Zhejiang Province’s technology-based small and medium-sized enterprises

Zhejiang Province Specialized, Sophisticated, and Novel Small and Medium-Sized Enterprises

Pharmaceutical starting materials

Pharmaceutical starting materials

Veterinary API and Intermediates

Animal protection active pharmaceutical ingredients and intermediates

Animal health preparations

Veterinary Drug Formulations

Animal Health CDMO: Active Pharmaceutical Ingredients + Finished Dosage Forms – One-Stop CMC Manufacturing Services

One-Stop Solution for CDMO APIs and Formulations, CMC, and Production

New materials

New Material

Pharmaceutical starting materials

01

Pharmaceutical starting materials

Starting materials for pharmaceuticals serve as the cornerstone of drug synthesis, and their quality directly impacts drug safety and efficacy. Leveraging a rigorous quality-control system and state-of-the-art manufacturing processes, our company ensures that these starting materials meet stringent international standards, thereby providing stable and reliable raw materials for downstream drug R&D and production and laying a solid foundation for the manufacture of high-quality medicines from the very outset.
探索详细
Veterinary API and Intermediates

02

Veterinary API and Intermediates

In the animal health sector, the company is dedicated to the R&D and production of active pharmaceutical ingredients and intermediates. By bringing together a team of highly skilled researchers, the company continuously explores innovative synthetic processes to develop products that are highly effective, safe, and environmentally friendly, thereby meeting diverse needs for the prevention and control of animal diseases. The company provides high-quality, critical raw materials to the global animal health industry, driving its sustainable development.
探索详细
Animal health preparations

03

Animal health preparations

The company boasts state-of-the-art formulation R&D technologies and production equipment, enabling the development of a diverse portfolio of animal health products—including tablets and injectables—tailored to specific animal species, disease profiles, and application scenarios. With a strong focus on formulation stability, bioavailability, and safety, the company optimizes formulation recipes and manufacturing processes to deliver convenient and effective solutions for livestock producers and veterinarians in managing animal diseases.
探索详细
Animal Health CDMO: Active Pharmaceutical Ingredients + Finished Dosage Forms – One-Stop CMC Manufacturing Services

05

Animal Health CDMO: Active Pharmaceutical Ingredients + Finished Dosage Forms – One-Stop CMC Manufacturing Services

Leveraging its deep expertise and comprehensive capabilities in the animal health sector, the company offers end-to-end CDMO services spanning drug R&D and CMC studies through to the scale-up production of active pharmaceutical ingredients and finished dosage forms. This integrated model helps clients shorten development timelines, reduce costs, and maintain stringent quality control to ensure product consistency, thereby accelerating the launch of high-quality products.
探索详细
New materials

04

New materials

Leveraging its robust R&D capabilities and advanced technology platforms, the company is actively engaged in the research, development, and application of new materials. Committed to creating high-performance, environmentally friendly, and sustainable materials, it aims to enable broad applications in areas such as pharmaceutical packaging and medical devices, thereby providing critical support for technological upgrades and product innovation across these industries and demonstrating a forward-looking commitment to innovation.
探索详细

CDMO SERVICES

Scope of Animal Health CDMO Services

End-to-end CDMO/CMO services for innovative animal health drugs, covering both active pharmaceutical ingredients and finished dosage forms throughout the entire product lifecycle.

Image Name

Process development,
Process optimization and

Analytics Services

Process development, process optimization, and analytical services

Scale-up production and clinical drug manufacturing

Method Development and Validation

Batch Production of Active Pharmaceutical Ingredients and Preparations for Clinical Use

Synthetic Route and Formulation Process Design

Process Optimization

Quality Research

Stability Study

Class I Class II

New Drug Application

Class I and Class II New Drug Applications

Process Validation

Registration and Approval

GMP certification

Commercialization
Production Services

Commercial Production Services

cGMP Commercial Production

Supply Chain Management

Continuous Cost Reduction and Optimization

Regulatory support (including generic drugs/derivatives, and Class 1 new drug approval applications)

Pharmaceutical Lifecycle Management

HONOR

PRODUCTION

Innovative R&D & Animal Welfare Production Capacity

The company places great emphasis on technological innovation, having recruited high-caliber talent—including national-level overseas experts, provincial-level overseas specialists, and recipients of the Provincial “151 Talent Program”—to form a cutting-edge R&D and management team. In addition, the company has established long-term industry–university–research collaboration partnerships with renowned domestic universities and research institutes, such as the Chinese Academy of Sciences and Zhejiang University.

R&D Achievements

R&D ACHIEVEMENTS

Animal Protection API

ANIMAL PROTECTION API

Animal health preparations

R&D ACHIEVEMENTS

探索详细
Image Name
System Certificate 7
System Certificate 6
System Certificate 5
System Certificate 4
System Certificate 3

NEWS

Stay up to date with the latest company news

GLOBAL SERVICES

Global Collaboration Services

The company not only delves deeply and meticulously into its three core business areas—veterinary API and intermediates, end-to-end veterinary CDMO services, and veterinary formulations—but also actively expands into global markets, establishing a broad and well-established global marketing network. Through collaboration withPfizer, Eli Lilly, Thermo FisherBy establishing long-term partnerships with internationally renowned pharmaceutical companies, the company’s products are now exported to numerous countries and regions worldwide, securing a prominent position in the global animal health market and continuously contributing to the global cause of animal health.
...

rongyao
非洲
亚洲
中国：台州、杭州、上海
南美洲
欧洲
北美洲
Africa
Algeria, Ethiopia, Ghana, Kenya, Malawi, South Africa, Sudan, Nigeria
大洋洲